Daily Judi: Friday, September 23, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Healthcare services provider Optum, a subsidiary of UnitedHealth Group, has altered how it licenses data to university-based researchers. (Stat)
In the wake of a slow response to COVID-19, Japan will invest $2 billion in vaccine initiatives for future epidemics. (Nature)
The National Institutes of Health (NIH) reports that clinical researchers found that insulin glargine and liraglutide are the best performers of medications approved by the U.S. Food and Drug Administration to maintain the recommended range of blood glucose levels.
The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team Judi will be there!
Our Culture
“We create a template so we can pull back the timelines and eliminate concerns around quality and risk—because everything’s already validated in the design. Then we can work faster with no risk to quality.”
–Jamie, Trial Delivery
About Judi
Judi empowers and enhances the world's clinical trial ecosystems. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.
